TARA generates human relevant data to enable faster, safer, and more accurate development of new treatments. Our platform can reduce cost and increase the success of important new medicines reaching patients.

Cardiac Drug Discovery

We generate disease models from stem cells, enabling discovery of new medicines for heart conditions.

Cardiac Safety

Our cardiac tissue models reliably represent adult human hearts when applied to drug testing. We can accurately identify cardiovascular complications.

Precision Cardiology

Our platform can be used to create custom cardiac models tailored to a single person, allowing for personalized health and treatment.


TARA Biosystems Presents Translational Disease Models at Keystone Heart Failure Symposium

Tuesday March 3, 2020 – Keystone, Colorado.  TARA Biosystems Inc. today reported data showcasing its Biowire™ II as a platform for heart failure drug discovery.  Speaking at this year’s READ MORE

Heart-on-a-Chip Technology Predicts Preclinical Systolic and Diastolic in vivo Observations for Novel Cardiac Drug in Development

TARA Biosystems, Inc. today reported in vivo and in vitro functional data from a study of investigational candidate, MYK-491, showing that TARA’s human…


TARA Biosystems Launches Cardiotype.Ca™ Cardiac Calcium Signaling Assay: In Vitro Assay Accelerates Drug Development in Human-Relevant Heart Models

​​ TARA Biosystems, Inc. launched Cardiotype.Ca™, its in vitro system for assessing cardiac calcium signaling. The new assay can be used independently or in combination…


Contact Us

Have a question? Want to request a study with TARA? Please fill out and submit the contact form, and we’ll get back to you as soon as we can.